Modified Stem Cells Show Promise in Reversing Type 1 Diabetes in Mice

Type 1 diabetes occurs when the immune system mistakenly attacks the insulin-producing beta cells in the pancreas. Scientists have long explored stem cells as a potential treatment, but growing them in the lab in ways that mimic the body's natural environment has been challenging.

Researchers at this institution developed a new system to grow stem cells as compact 3D structures called spheroids. These spheroids maintain properties that make them more 'stem-like' and potent than cells grown flat in a dish. The team then modified these spheroids to produce insulin without permanently changing their DNA.

When the modified stem cell spheroids were transplanted into diabetic mice, blood sugar levels improved and the mice showed better glucose tolerance. Importantly, the mice's own insulin production and C-peptide levels increased—a sign that their remaining pancreatic function was improving.

Surprisingly, researchers found no evidence that the transplanted cells engrafted into the pancreas itself. This suggests the stem cells worked indirectly, rather than directly replacing the destroyed beta cells.

Further analysis revealed the likely mechanism: the modified stem cells reduced inflammation throughout the body, shifted immune cells toward a more tolerant state, and enhanced metabolic signaling. Specifically, the treatment promoted M2 macrophages—immune cells associated with healing and reduced inflammation—and increased regulatory T cells, which help prevent autoimmune attack.

This finding is significant because it suggests the therapy works by calming the immune system's attack on the pancreas, rather than simply providing new insulin-producing cells.

This research is proof-of-concept in mice. The approach avoids permanent genetic modification by using temporary insulin expression, which addresses a key safety concern in stem cell therapy. However, human studies have not yet begun, and it remains unclear whether the approach will be equally effective in people.

The work opens a new direction for combining stem cell biology with immune tolerance—two areas that researchers have explored separately but rarely together in Type 1 diabetes treatment.

Source: Stem cells translational medicine. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.